It is providedexclusively for scientific, laboratory, and investigational research and is not intended for human or veterinary use
The decision to continue depends on individual response, tolerance, and whether weight loss targets have been met
Historically, research focused on identifying AD drug targets and interventions have experienced significant failures with a 1% success rate (8)
A 2024 study suggests you may get better weight loss results with tirzepatide, the active ingredient in Zepbound and Mounjaro, than with semaglutide, the active ingredient in Ozempic and Wegovy
Skin Brightening & Even Skin Tone Uneven skin tone, dark spots, or pigmentation
Minor transient effects often resolve within 1-2 weeks as your body adapts